A Phase 3 Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy andSafety of Pimodivir in Combination With the Standard-of-care Treatment in Adolescent, Adult, ElderlyHospitalized Patients With Influenza A Infection

Medicine & Life Sciences

1. Standard of Care 100%
2. Human Influenza 95%
3. Multicenter Studies 89%
4. Placebos 71%
5. Infections 49%
6. Elderly 34%
7. Safety 30%
8. Therapeutics 16%